240 related articles for article (PubMed ID: 28971065)
1. Preclinical Modeling and Therapeutic Avenues for Cancer Metastasis to the Central Nervous System.
Singh M; Bakhshinyan D; Venugopal C; Singh SK
Front Oncol; 2017; 7():220. PubMed ID: 28971065
[TBL] [Abstract][Full Text] [Related]
2. Overview of resistance to systemic therapy in patients with breast cancer.
Gonzalez-Angulo AM; Morales-Vasquez F; Hortobagyi GN
Adv Exp Med Biol; 2007; 608():1-22. PubMed ID: 17993229
[TBL] [Abstract][Full Text] [Related]
3. RNAi screen identifies essential regulators of human brain metastasis-initiating cells.
Singh M; Venugopal C; Tokar T; Brown KR; McFarlane N; Bakhshinyan D; Vijayakumar T; Manoranjan B; Mahendram S; Vora P; Qazi M; Dhillon M; Tong A; Durrer K; Murty N; Hallet R; Hassell JA; Kaplan DR; Cutz JC; Jurisica I; Moffat J; Singh SK
Acta Neuropathol; 2017 Dec; 134(6):923-940. PubMed ID: 28766011
[TBL] [Abstract][Full Text] [Related]
4. Brain metastases in patients diagnosed with a solid primary cancer during childhood: experience from a single referral cancer center.
Suki D; Khoury Abdulla R; Ding M; Khatua S; Sawaya R
J Neurosurg Pediatr; 2014 Oct; 14(4):372-85. PubMed ID: 25127097
[TBL] [Abstract][Full Text] [Related]
5. The Underlying Biology and Therapeutic Vulnerabilities of Leptomeningeal Metastases in Adult Solid Cancers.
Dankner M; Lam S; Degenhard T; Garzia L; Guiot MC; Petrecca K; Siegel PM
Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578853
[TBL] [Abstract][Full Text] [Related]
6. Characteristics and Outcomes of Patients With Breast Cancer With Leptomeningeal Metastasis.
Morikawa A; Jordan L; Rozner R; Patil S; Boire A; Pentsova E; Seidman AD
Clin Breast Cancer; 2017 Feb; 17(1):23-28. PubMed ID: 27569275
[TBL] [Abstract][Full Text] [Related]
7. Modeling metastasis in vivo.
Khanna C; Hunter K
Carcinogenesis; 2005 Mar; 26(3):513-23. PubMed ID: 15358632
[TBL] [Abstract][Full Text] [Related]
8. Molecular determinants of lung cancer metastasis to the central nervous system.
Whitsett TG; Inge LJ; Dhruv HD; Cheung PY; Weiss GJ; Bremner RM; Winkles JA; Tran NL
Transl Lung Cancer Res; 2013 Aug; 2(4):273-83. PubMed ID: 25806243
[TBL] [Abstract][Full Text] [Related]
9. Molecular Biology of Brain Metastases.
Gwak HS
Brain Tumor Res Treat; 2023 Jan; 11(1):8-15. PubMed ID: 36762803
[TBL] [Abstract][Full Text] [Related]
10. Increased detections of leptomeningeal presentations in men with hormone refractory prostate cancer: an effect of improved systemic therapy?
Lin C; Turner S; Gurney H; Peduto A
J Med Imaging Radiat Oncol; 2008 Aug; 52(4):376-81. PubMed ID: 18811763
[TBL] [Abstract][Full Text] [Related]
11. Brain metastasis in lung cancer: Building a molecular and systems-level understanding to improve outcomes.
Ebben JD; You M
Int J Biochem Cell Biol; 2016 Sep; 78():288-296. PubMed ID: 27474492
[TBL] [Abstract][Full Text] [Related]
12. More advantages in detecting bone and soft tissue metastases from prostate cancer using
Pianou NK; Stavrou PZ; Vlontzou E; Rondogianni P; Exarhos DN; Datseris IE
Hell J Nucl Med; 2019; 22(1):6-9. PubMed ID: 30843003
[TBL] [Abstract][Full Text] [Related]
13. Brain Metastases and Place of Antiangiogenic Therapies in Alveolar Soft Part Sarcoma: A Retrospective Analysis of the French Sarcoma Group.
Malouf GG; Beinse G; Adam J; Mir O; Chamseddine AN; Terrier P; Honore C; Spano JP; Italiano A; Kurtz JE; Coindre JM; Blay JY; Le Cesne A
Oncologist; 2019 Jul; 24(7):980-988. PubMed ID: 30626710
[TBL] [Abstract][Full Text] [Related]
14. Development of a preclinical model of spontaneous human melanoma central nervous system metastasis.
Cruz-Munoz W; Man S; Xu P; Kerbel RS
Cancer Res; 2008 Jun; 68(12):4500-5. PubMed ID: 18559492
[TBL] [Abstract][Full Text] [Related]
15. Modeling growth kinetics and statistical distribution of oligometastases.
Withers HR; Lee SP
Semin Radiat Oncol; 2006 Apr; 16(2):111-9. PubMed ID: 16564446
[TBL] [Abstract][Full Text] [Related]
16. In vivo magnetic resonance imaging investigating the development of experimental brain metastases due to triple negative breast cancer.
Hamilton AM; Foster PJ
Clin Exp Metastasis; 2017 Feb; 34(2):133-140. PubMed ID: 28108861
[TBL] [Abstract][Full Text] [Related]
17. UBE2C promotes leptomeningeal dissemination and is a therapeutic target in brain metastatic disease.
Paisana E; Cascão R; Custódia C; Qin N; Picard D; Pauck D; Carvalho T; Ruivo P; Barreto C; Doutel D; Cabeçadas J; Roque R; Pimentel J; Miguéns J; Remke M; Barata JT; Faria CC
Neurooncol Adv; 2023; 5(1):vdad048. PubMed ID: 37215954
[TBL] [Abstract][Full Text] [Related]
18. Reactive Astrocytes in Brain Metastasis.
Wasilewski D; Priego N; Fustero-Torre C; Valiente M
Front Oncol; 2017; 7():298. PubMed ID: 29312881
[TBL] [Abstract][Full Text] [Related]
19. A summary of two clinical studies on tumor cell dissemination in primary and metastatic breast cancer: methods, prognostic significance and implication for alternative treatment protocols (Review).
Kasimir-Bauer S; Oberhoff C; Schindler AE; Seeber S
Int J Oncol; 2002 May; 20(5):1027-34. PubMed ID: 11956600
[TBL] [Abstract][Full Text] [Related]
20. Epidemiology, Treatment, and Complications of Central Nervous System Metastases.
Pruitt AA
Continuum (Minneap Minn); 2017 Dec; 23(6, Neuro-oncology):1580-1600. PubMed ID: 29200112
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
